chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous non-valid social media report was received from a consumer (patient's mother) and refers to a male patient of unknown age. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patient was vaccinated with the second dose of GARDASIL (exact dose, route, lot # and expiration date were not reported). On an unknown date, after this second shot, patient became ill. He had extreme fatigue and muscle aches. At times he developed upper neck pain and muscle weakness, especially in his legs. His life completely changed and physical activity was very difficult for him. It was reported that the patient still suffered at the time of the report and those events were a long term effects. The patient's mother reported her son's reaction to Vaccine Adverse Event Reporting System (VAERS). The outcome of the events was reported as not recovered/not resolved. The relatedness between the events and GARDASIL was not reported. Additional information is not expected as no contact details were provided.
Information has been received from a registered nurse referring to a patient of unknown age and gender on 20-OCT-2017. There was no information about patient's concurrent conditions, medical history or concomitant medications. On 27-SEP-2017, the patient was vaccinated with improperly stored VARIVAX lot # N012131 and expiration date of 17-APR-2019, (route of administration and anatomical location were not reported) for prophylaxis, reconstituted with properly stored sterile diluent (MERCK STERILE DILUENT) (lot # unknown), The vaccines were stored in the range of 6 Farenheit degrees to 14 Farenheit degrees for 3 hours and 40 minutes. No previous temperature excursion was reported. The patient did not experience any adverse events. Digital data logger was involved. This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1709USA007342: US-009507513-1710USA014743: US-009507513-1710USA014744: US-009507513-1710USA014745: US-009507513-1710USA014746: US-009507513-1710USA014748: US-009507513-1710USA014749:
Patient received half dose of Moderna vaccine on 30-Dec-2021 followed by full dose on 08-Feb-2022 for the primary series; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received half dose of Moderna vaccine on 30-Dec-2021 followed by full dose on 08-Feb-2022 for the primary series) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.   On 30-Dec-2021, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 08-Feb-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 08-Feb-2022,  after starting mRNA-1273 (Spikevax), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received half dose of Moderna vaccine on 30-Dec-2021 followed by full dose on 08-Feb-2022 for the primary series). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient received half dose of Moderna vaccine on 30-Dec-2021 followed by full dose on 08-Feb-2022 for the primary series) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   Concomitant drugs were not reported. Treatment medications were not provided.   This case was linked to MOD-2022-607775 (Patient Link).
Headaches for six weeks, daily, not responsive to Tylenol, fatigue, occasional dizziness, dry throat.
Pt reports having severe cold like symptoms that started immediately after his influenza vaccine that he received last week. Had fever, cough and body aches which lasted several days. He also c/o having severe soreness in the left arm and is now unable to move the shoulder due to pain. Denies having rash or anaphylactic symptoms. He has since improved but still is having productive cough and left shoulder impairment. Musculoskeletal - abnormal exam of left shoulder; unable to fully examine due to Pain. TTP focal at origin of the biceps tendon. TENDINITIS OF LEFT BICEPS TENDON. Note: Unclear if this was related to the vaccine or not. He looks like he may have a frozen shoulder vs biceps tendonitis. He declines any nsaids or PT. Agreeable to icing only.
Patient had no problems, but wednesday evening (the 13th of october) at 7pm. Her right wrist started becoming swollen and red and patient felt a burning/itching sensation travel up arm and right side of face also started to swell, turn red, and felt like burning/itching. By 930p, There were generalized red,swollen patches on various parts on the right side of body, including under right breast and right ankle. Patient still experiencing symptoms today, and RPh advised patient to take some benadryl (originally reason for call). RPh (reporter) also recommmended see dr, but patient said she would not unless it got worse.
This spontaneous report as received from a medical assistant refers to multiple patients of unknown demographics. On unknown dates the patients possibly received improperly stored doses of (wistar ra 27-3) M-M-R II (lot # L036853 with expiry date: 24-SEP-2017, L043702 with expiry date: 03-NOV-2017, M007277 with expiry date: 09-FEB-2018) (incorrect product storage). The temperature and timeframe that the (wistar ra 27-3) M-M-R II were exposed to were as follows: Temperature. 50.4F. Time frame: 19.5 hours total cumulative. Lot numbers and expiry dates of these specific vaccines that administered were unknown. Lot # M008589 with expiry date: 16-FEB-2018 were administered on 10-AUG-2016, 11-AUG-2016 and 12-AUG-2106 (on 10-AUG-2016, temperature excursion of 47.7 and 47.3 degree Celsius happened for a duration of 1 hour, on 11-AUG-2016, temperature excursion of 50.4-46.8 degree Celsius happened for a duration of 6 hours). Lot # L049316 with expiry date: 03-DEC-2017 were administered on 12-AUG-26 and 15-AUG-216 (on 12-AUG-2016, temperature excursion of 45.5 and 47.7 degree Celsius happened for a duration of 6 hours, on 15-AUG-2016, temperature excursion of 44.6-47.3 degree Celsius happened for a duration of 1 hour 45 min and on 16-AUG-2016, temperature excursion of 46.8 degree Celsius happened for a duration of 1 hour). No adverse effects reported. The outcome was unknown. No product quality complaint was involved. This is one of several reports received from the same reporter. Additional information has been requested.
On July 20, 2017 a male patient received an intradermal injection of MassBiologics' Td vaccine (Lot #A090A) in his right arm instead of a PPD administration; the dose of Td administered was 0.1mL and not the 0.5mL labeled dose. The reporter would not disclose his date of birth but indicated he was in his mid to late 50's. The patient experienced same day onset of soreness around the injection site. The following day the patient experienced injection site induration (at least 10 mm in size), injection site erythema (~20cm x 8cm), and red streaks at the injection site but reported to not be cellulitis. The patient went to an Urgent Care facility on July 22, 2017 and was given a treatment plan of 500mg of KEFLEX for 10 days. At the time of the initial report, 7 days post-administration, the patient had recovered from all events except the injection site induration which had decreased to ~6mm. Follow up obtained on August 3, 2017 indicated that the induration was barely 6mm in size and was less-defined with minimal fine edges. Final follow up on August 15, 2017 indicated that all symptoms had completely resolved. The primary reporter indicated that the drug administration error occurred because the physical appearance of the Td vial label and the PPD vial label were very similar in color and pop top. In addition, the primary reporter said that "Tetanus" and "Tuberculin" look very similar when in a rush. Sender's Comments: All adverse events reported in this case were assessed as non-serious and labeled. MassBiologics sent a letter containing information regarding this event to the manufacturer of the PPD not administered, PAR Sterile Products, on August 25, 2017.
Weakness, nausea, body aches, loss of vision the evening of the vaccine. Took a nap and SX went away.
Nurse administered too much vaccine.  Checked on patient today.  Sorness at injection site, headache and fever.  Advised to monitor for worsening symptoms.
3/3: Woke up with headache that got continuous. Took acetaminophen and alternated with ibuprofen every 4 hours. Around 2:00pm, uncontrolled shivering due to chills started. By 3:30, had muscle\joint pain in back and began feeling lightheaded. At 5:30, was unsteady on feet, pounding headache, fever of 101.8F and no appetite for dinner. Fell asleep on couch, woke at 7:30 pm, discontinued ibuprofen and acetaminophen, took 500mg Excedrin, fever of 102.8F and went to bed. Uncontrolled shivering resumed around 8:30pm, woke up several times during the night drenched in sweat and took ibuprofen at 4:30 am. Awoke at 8:30 am on 3/4 drenched in sweat again, took hot shower, had light breakfast and took 500mg Excedrin. Temperature is currently 99.3F
Fever, pain and swelling on injected arm which lasted for 4 days.  MD prescribed antibiotic for possible cellulitis.
I started to feel a hot sensation (felt the same way after receiving the first dosage of the vaccine and had to have blood pressure taken while I was waiting and I also developed a rash/swelling...went away the next day) everywhere and later that evening I felt like the needle was still in my arm.  The pain was sharp and continued and then it went from that to where I was cooking (picked up a pan and dropped it because I couldn't grip anything). I woke up and felt like my arm was five times bigger than it should be. It was a sensation that I continually felt and even to this day.  The first telephone visit was 06/28/2021 with a doctor and two to three days after that I talked to my PCP on the phone.  I let my doctor know that I would rather not come in and only wanted the symptoms documented in hopes that they will go away. Please note: the first doctor brushed me off as if I were complaining to get attention. My PCP was not happy when I told him what transpired during the conversation with the doctor. The symptoms that continue to be with me now are my left hand and arm are still painful and feels like their swollen even though only my hand is but not my arm (cannot wear my wedding ring).
Information has been received from a nurse practitioner concerning a patient who was vaccinated with ZOSTAVAX on 17-SEP-2012. On 19-SEP-2012, the patient developed "a rash scattered on the upper torso." At the time of the report, the patient had not recovered. Additional information is not expected.
throbbing And major joint pain; tingling; joint pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (throbbing And major joint pain), PARAESTHESIA (tingling) and ARTHRALGIA (joint pain) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. ASKU) for COVID-19 prophylaxis.     It was unknown if patient had received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (throbbing And major joint pain), PARAESTHESIA (tingling) and ARTHRALGIA (joint pain). At the time of the report, PAIN (throbbing And major joint pain), PARAESTHESIA (tingling) and ARTHRALGIA (joint pain) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication information provided.  No treatment information provided.
Information has been received from a nurse practitioner concerning a female (age not reported) who on an unspecified date was vaccinated with her first and only dose of GARDASIL 0.5 mL.  There was no concomitant medication.  Subsequently "one week after vaccination" the patient developed total body paralysis and was hospitalized and all the lab tests which included a complete blood cell count came back negative.  Several days after the hospitalization, the patient got better and was released.  The reporter considered that total body paralysis to be disabling.  Additional information has been requested.  6/25/2008 MR received for ER visit 3/26/2008 with DX: Quadriparesis-resolved. Pt developed a h/a, took a nap and awoke with inability to move all 4 extremities. Parent reports that this is the 3rd episode of these sx. During triage, unable to move 4 extremities. 1 hr later continued to have some motor and sensory deficits.  Tingling reported in legs. Able to move toes after several hours and ambulating with slow unsteady gait and jerky movements in several more. D/C with resolution of sx in ~6 hrs from arrival.
11-2-09 - No symptoms.  Received vaccine. 11-3-09 - No symptoms. 11-4-09 at 5PM 100.3 T, 9P 104 degrees. 11-5-09 AM 100 degrees increased before noon 104 degrees - 102 no treatment.  Received a call fron the nurse stating that the patience's fever returned on 11/06/09 and the patience was taken to his doctor and was DX with the flu. The doctor prescribed Tamaflu for the patient.
Subsequently the pt developed hives.  The hives developed very quickly after receiving the vax. The pt sought unspecified medical attention. Additional information has been requested.
This spontaneous report has been received from a medical assistant refers to a 14 month old patient (gender unknown). No information was provided regarding the patient's medical history, concurrent conditions, drug and allergy history. On 02-AUG-2018, the patient was vaccinated with PROQUAD (strength, dose, frequency, route of administration, lot# and expiration date were not provided) for prophylaxis. It was reported that on the same date, the patient received an unspecified dose of VARIVAX (strength, frequency, route of administration, lot# and expiration date were not provided) for prophylaxis (overdose). Concomitant therapies included sterile diluent (MRK STERILE DILUENT). No adverse effect was reported.
Vominting within 1 hr of vaccine. Extream arm pain. Temp of 102. Hallucination with extream chills and body aches.
Patient broke out in rash and whelps the day after vaccine.  They are resolving slowly now (3 days later)
This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (101.3 fever), MYALGIA (Body ache), CHILLS (some chills) and FATIGUE (general fatigue) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 02-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (101.3 fever), MYALGIA (Body ache), CHILLS (some chills) and FATIGUE (general fatigue). At the time of the report, PYREXIA (101.3 fever), MYALGIA (Body ache), CHILLS (some chills) and FATIGUE (general fatigue) had not resolved. Not Provided. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available):On an unknown date, Body temperature: 101.3 (abnormal) 101.3 degree Fahrenheit. No concomitant medications were reported.  Treatment information was not provided.
constipation; This spontaneous case was reported by a patient and describes the occurrence of CONSTIPATION (constipation) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Surgery (A year ago the patient was diagnosed with a geo blastoma with a mass the size of an avocado that was removed from his brain) and Radiation therapy in December 2020.   On 24-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CONSTIPATION (constipation). At the time of the report, CONSTIPATION (constipation) outcome was unknown. Not Provided          No concomitant medications were reported.  No treatment information was reported.  Action taken with mRNA-1273 in response to the events was not Applicable   This case was linked to MOD21-062435 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-057927:MOD-2021-057927 - 2nd dose of vaccine.
Pt recvd vax on 14AUG92 & 1 wk later pain in the lt hip intensified again; lab eval on 14AUG92 & 5OCT92 revealed a neg anti-HBs; MD felt exp was not related to the vax, however, advised the pt to not receive a 5th dose;
First developed a swollen lymph node in left armpit as I had with previous vaccines. Gradually noticed a hardening lump in inner, upper left arm. Over a week or more this became a firm cord-like structure down my left, inner arm along the bicep. After 2 weeks it had not gotten better so went to see Dr. He ordered ultrasound. It showed thrombophlebitis. No clot.
Pt has a history of fainting after intramuscular injections. Pt states that immediately after receiving the vaccine he started feeling faint. Pt was moved to exam room and monitored. Pt recovered.
Within 2 hours of the inactivated vaccine administration, pt complains of fever of 102 F, myalgia, congestion, malaise, injection site pain.
This spontaneous report was received from a pharmacist refers to a 65 year old male patient with diabetes and sulfa allergy. On 22-JUN-2013, the patient was vaccinated with a dose of ZOSTAVAX (lot # J001008, expiry: 24-APR-2014), 0.65 ml, subcutaneously in the left arm. No concomitant medications were reported. On 23-JUN-2013, the patient was a little sore. The patient came back to the pharmacy on 25-JUN-2013, with redness around the injection site but not much pain. The patient sought medical attention. No treatment was given to patient. No laboratory diagnostic tests were performed. The outcome of the events was reported as not recovered. Additional information is not expected.
I was given the shot high on my right arm on 09/06/2011. This was in the PM, I went home and went to bed. When I woke up, I had severe pain in both of my arms, and pain in my right arm radiating to my shoulder and my back. My fiance told me my back was swollen and red and also looked raised with a rash. My back was burning and painful to the touch, and so was my shoulder. I also started to get hive like spots on my chest and back. I immediately put an icepak on my back and started taking Benadryl 50 mg every four hours. They next day I started having "internal itching". I was itching in places you could not scratch like my eyes, my ears, and also topical itching. The itching was severe. I called my doctor and told them about it when no symptoms disappeared approx. 5 days later. They fit me in with another doctor who was not considered my primary. I got very poor care, I was told that my "allergy wasn't that bad". and I asked for prescription Benadryl, prednisone and some cortisone valerate cream. The doctor refused to give me any prescriptions. My pharmacy told me she sent an electronic prescription for the hydrocortizone valerate cream, but never returned the phone call for authorization. Since September 7th, I am still taking Benadryl every 6 hours, and if I miss a dose, the itching becomes un bearable. I am also using topical over the counter Cortizone 10. I went back to the doctor on 09/26/2011 and told my primary I was still itching and showed her my rash. She told me to stop the Benadryl even after I told her the internal itching was severe, telling me Benadryl is addictive? Anyway I told her no, if I stop it I could not go to work, the itching is severe. She gave me no meds, but a referral to an allergist.
Since 21 January he has complained of recurrent episodes of generalized itching and rashes described as raised, red, itchy whelts which can occur anywhere on his body, especially at sites of pressure or where his skin is scraped or scratched. Lesions last less than 24 hours, spares his palms and soles, and resolve without post-inflammatory changes. He denies laryngeal, pulmonary, GI, neurologic, and cardiovascular symptoms with these episodes. Episodes initially also associated with hot showers but currently not associated with heat, exercise, sweating, cold, foods, medications, NSAIDs, IV contrast, latex exposure, known infections, or insect bites/stings. He received his Moderna COVID-19 vaccine booster dose on 7 January, 14 days prior to onset of symptoms. He has used oral antihistamines with some benefit. He denies constitutional symptoms. UCT score today is 13 (1, 2, 1, 0, 1, 4, 1, 3). No history of adverse reactions to prior vaccines.
Temp. to 103 degrees two-three (2-3) hours after the vaccine was administered.  Severe abdominal pain upper Right quadrant to midline.  Fever lasted more than 12 hours even after Tylenol was given.  Adolescent dose for 1st dose (6/03);  Adult dose for #2
I had longer heavier periods and spotting inbetween for 6months immediately following the vaccine. Never in my life had my cycle been like that.
My mother got this shot then several hours later started with arm pain, then chills. Nausea, dizziness and her blood pressure continuously had risen until at 930 pm she had a seizure as of 12 noon on 11/08/2016 she complains of nausea, muscle aches, fatigue, sleepiness and chills. She should NOT have had this shot and by her records and the insert of this medication the doctor should have known this!
Pt passed out about a minute after receiving flu vaccine she came back around within 2 minutes and stayed in our office for 15 minutes after.
Caller seeking recommendation for a patient who has covid on when to retest if they are fully vaccinated; Caller seeking recommendation for a patient who has covid on when to retest if they are fully vaccinated; This is a spontaneous report received from a non-contactable reporter(s) (Pharmacist) from medical information team.  A patient (no qualifiers provided) received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "Caller seeking recommendation for a patient who has covid on when to retest if they are fully vaccinated". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: seeking recommendation for patient who has covid on when to retest.  Clinical course: Reporter was seeking recommendation for a patient who has covid on when to retest if they are fully vaccinated, stated their symptoms had worsened.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient developed extreme back pain. Was placed in room and vitals all normal. Then developed rash on arms and back and abdomen still have back pain. Was given 2 ES TYLENOL and BENADRYL 25 mg. Back pain started to diminish. Then started to get chills. Back pain resolved vitals were monitored as well as patient for her symptoms totally went away. Spoke to patient day after and had no symptoms. Pt was able to ambulate without difficulty prior to discharge and lower extremity strength was 5/5. She had no shortness of breath tongue or lip swelling, no wheezing.